NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Techcyte, Inc.

Techcyte, Inc.

Private
Orem, UtahHealthcare & Life Scienceshttps://techcyte.com/

Last Round

VC Round

Apr 30, 2026

Total Funding Raised

$34.61M

Momentum

Top 1%

of companies Caplight tracks

Company Overview

Techcyte, Inc. is a healthtech company that provides an AI-powered digital pathology platform for anatomic and clinical pathology.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Medical Imaging, Healthcare Analytics, Biotechnology, Vertical SaaS

Business Model

B2B

Customer Profile

Subscription SaaS, Usage-Based SaaS

AI Layer

Application

Keywords

digital pathologymedical AIAI diagnosticswhole slide imagingpathology AIveterinary diagnosticsimage analysis softwarelaboratory information systemLISvertical SaaSclinical diagnosticsdeep learningpathology workflowcomputational pathologyautomated microscopy

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Techcyte, Inc. Comparables

Compare Techcyte, Inc. with similar companies based on industry and business-model similarity.

Techcyte, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Proscia
87%
Deciphex
84%
AIRA Matrix
84%

Techcyte, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundApr 30, 2026
VC RoundJan 11, 2024
Series EAug 18, 2021
SeedJan 18, 2018
Series AJan 18, 2018
Seed
Mar 1, 2016

Key People

Founding team and executive leadership

Ben Cahoon

Chief Executive Officer

Executive Team

Techcyte, Inc. Investors

Notable investors and investment history

Techcyte, Inc. investors
InvestorRounds
Mayo Clinic VenturesVC Round
Van Tuyl CompaniesVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 20, 2026

    Open roles increased to 32, representing 27% of headcount.

  • Apr 30, 2026

    $15M raised, led by Van Tuyl Companies.

Techcyte, Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Techcyte, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Techcyte, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersOrem, Utah
Employee Range120
Year Founded2013
Last FundingApr 30, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.